Financials
- Market Capitalization 10.24 B
- Employee 507
- Founded 2013
- CEO N/A
- Website www.vaxcyte.com
- Headquarter Delaware, United States
- FIGI BBG009PHHPL8
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-8.2
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 867 | MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 453.55 USD | -2.91% | -8.97% | -16.01% | +7.07% | 10.48 B USD | ||
| 870 | IBRX ImmunityBio, Inc. - Common Stock | 9.87 USD | -2.47% | -0.80% | +25.10% | +306.17% | 10.46 B USD | ||
| 888 | KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 79.16 USD | -0.10% | +3.90% | +1.63% | +99.67% | 10.07 B USD | ||
| 914 | KRYS Krystal Biotech, Inc. - Common Stock | 323.64 USD | -2.54% | -2.12% | -7.73% | +72.95% | 9.58 B USD |